Verona Pharma Plc - ADR
VRNA
Market Cap$6.18B
Close$
$34.81
47.5% downside
Current Fair Value
47.5% downsideOvervalued by 47.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $6.18 Billion |
|---|---|
| Enterprise Value | $5.79 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-2.16 |
| Beta | 0.16 |
| Outstanding Shares | 84,925,625 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -37.66 |
|---|---|
| PEG | -19.56 |
| Price to Sales | - |
| Price to Book Ratio | 33.13 |
| Enterprise Value to Revenue | 882.53 |
| Enterprise Value to EBIT | -36.44 |
| Enterprise Value to Net Income | -38 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Verona Pharma Plc
CEO: David Zaccardelli